Approval Order StatementApproval for the addition of the antibiotic cefotaxime at concentrations of 0. 06, 0. 25, 0. 5 and 1 micrograms/ml to the vitek(r) 2 s. Pneumoniae susceptibility test system. The device will be marketed under the trade name vitek(r) 2 s. Pneumoniae susceptibility test cards for use in the vitek 2 system and is indicated for use for the susceptibility testing of streptococcus pneumoniae to cefotaxime in the range of <=0. 06 to >=4 micrograms/ml.